Louise Stanton
Impact in
- Hepatology top 2%
- Hepatocellular Carcinoma Treatment and Prognosis
- Oncology top 5%
- Colorectal Cancer Treatments and Studies
- CAR-T cell therapy research
- Cancer Risks and Factors
Papers in
-
- Lymphoma Diagnosis and Treatment 16
- Oncology 17
- CAR-T cell therapy research 7
- Viral-associated cancers and disorders 4
- Colorectal Cancer Treatments and Studies 3
- Co-authors
- Tom Maishman (12 shared papers)Lorraine Durcan (4 shared papers)Diana M. Eccles (4 shared papers)Ellen Copson (4 shared papers)Bryony Eccles (4 shared papers)J. Louise Jones (3 shared papers)Ramsey Cutress (3 shared papers)Gregory Mark Peterson (3 shared papers)
- Journals
- Trials (8 papers)Blood (6 papers)The Lancet Oncology (4 papers)Health Technology Assessment (3 papers)Hematological Oncology (3 papers)
- Partner nations
- United KingdomSwitzerlandAustralia
In The Last Decade
Louise Stanton
55 papers receiving 2.2k citations
Louise Stanton's Hit Papers
Peers
Comparison fields: 5 of 112
- Hepatology 364
- Oncology 897
- Pathology and Forensic Medicine 461
- Cancer Research 358
- Geriatrics and Gerontology 43
Countries citing papers authored by Louise Stanton
This map shows the geographic impact of Louise Stanton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Louise Stanton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Louise Stanton more than expected).
Fields of papers citing papers by Louise Stanton
This network shows the impact of papers produced by Louise Stanton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Louise Stanton. The network helps show where Louise Stanton may publish in the future.
Co-authors
The 25 scholars most cited alongside Louise Stanton, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 58 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Germline BRCA mutation and outcome in young-onset breast cancer (POSH): a prospective cohort study Hit paper breakdown → | 2018 | 338 |
| 2 | Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis: the New EPOC randomised controlled trial Hit paper breakdown → | 2014 | 327 |
| 3 | 2019 | 210 | |
| 4 | 2020 | 174 | |
| 5 | 2013 | 171 | |
| 6 | 2016 | 101 | |
| 7 | 2016 | 97 | |
| 8 | 2014 | 78 | |
| 9 | 1994 | 66 | |
| 10 | 2013 | 64 | |
| 11 | 2013 | 56 | |
| 12 | 2023 | 48 | |
| 13 | 2015 | 44 | |
| 14 | 2019 | 42 | |
| 15 | 2017 | 41 | |
| 16 | 2015 | 34 | |
| 17 | 2015 | 34 | |
| 18 | 2017 | 28 | |
| 19 | 2015 | 27 | |
| 20 | 1997 | 26 |
About Louise Stanton
Louise Stanton is a scholar working on Pathology and Forensic Medicine, Oncology, Genetics, Hepatology and Public Health, Environmental and Occupational Health, having authored 58 papers that have together received 2.2k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (16 papers), Chronic Lymphocytic Leukemia Research (8 papers), CAR-T cell therapy research (7 papers), Hepatocellular Carcinoma Treatment and Prognosis (6 papers), Viral-associated cancers and disorders (4 papers), Acute Lymphoblastic Leukemia research (3 papers), Urinary Tract Infections Management (3 papers) and Colorectal Cancer Treatments and Studies (3 papers). The work is most often cited by research in Hepatology (364 citations), Oncology (897 citations), Pathology and Forensic Medicine (461 citations), Cancer Research (358 citations) and Geriatrics and Gerontology (43 citations). Louise Stanton has collaborated with scholars based in United Kingdom, Switzerland and Australia. Frequent co-authors include Tom Maishman, Lorraine Durcan, Diana M. Eccles, Ellen Copson, Bryony Eccles, J. Louise Jones, Ramsey Cutress, Gregory Mark Peterson, Peter Simmonds and Douglas G. Altman. Their work appears in journals such as Trials, Blood, The Lancet Oncology, Health Technology Assessment and Hematological Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.